1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA HNRNPM CTRPv2 pan-cancer AAC 0.18 1e-07
mRNA SSBP4 CTRPv2 pan-cancer AAC 0.18 1e-07
mRNA DDX39B CTRPv2 pan-cancer AAC 0.18 1e-07
mRNA RBM10 CTRPv2 pan-cancer AAC 0.19 1e-07
mRNA HNRNPA1 CTRPv2 pan-cancer AAC 0.2 1e-07
mRNA WASF1 CTRPv2 pan-cancer AAC 0.19 1e-07
mRNA SOCS7 CTRPv2 pan-cancer AAC 0.17 1e-07
mRNA PTBP1 CTRPv2 pan-cancer AAC 0.18 1e-07
mRNA INTS7 CTRPv2 pan-cancer AAC 0.18 1e-07
mRNA PLEKHO1 CTRPv2 pan-cancer AAC 0.19 1e-07
Download CSV